Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för ryuvidine. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

10 träffar

Bibliografisk träff 2024-02-29

Epidrugs: alternative chemotherapy targeting <i>Theileria annulata</i> schizont stage parasites.

Kamble S, Singh S, Suresh A, Singothu S, Dandesena D, Bhandari V, Sharma P.

Microbiol Spectr · brief-report; research support, non-u.s. gov't; journal article · DOI 10.1128/spectrum.03258-23

Bibliografisk träff 2022-06-01

Epigenetic regulator UHRF1 orchestrates proinflammatory gene expression in rheumatoid arthritis in a suppressive manner.

Saeki N, Inoue K, Ideta-Otsuka M, Watamori K, Mizuki S, Takenaka K, Igarashi K, Miura H, Takeda S, Imai Y.

J Clin Invest · research support, non-u.s. gov't; research-article; journal article · DOI 10.1172/jci150533

Bibliografisk träff 2021-05-24

Isolation and Establishment of a Highly Proliferative, Cancer Stem Cell-Like, and Naturally Immortalized Triple-Negative Breast Cancer Cell Line, KAIMRC2.

Ali R, Al Zahrani H, Barhoumi T, Alhallaj A, Mashhour A, Alshammari MA, Alshawakir YA, Baz O, Alanazi AH, Khan AL, Al Nikhli H, Al Balwi MA, Al Riyees L, Boudjelal M.

Cells · research support, non-u.s. gov't; research-article; journal article · DOI 10.3390/cells10061303

Bibliografisk träff 2019-07-09

Identification of ryuvidine as a KDM5A inhibitor.

Mitsui E, Yoshida S, Shinoda Y, Matsumori Y, Tsujii H, Tsuchida M, Wada S, Hasegawa M, Ito A, Mino K, Onuki T, Yoshida M, Sasaki R, Mizukami T.

Sci Rep · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/s41598-019-46346-x

Bibliografisk träff 2018-05-25

High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell lines.

Ghasemi F, Black M, Sun RX, Vizeacoumar F, Pinto N, Ruicci KM, Yoo J, Fung K, MacNeil D, Palma DA, Winquist E, Mymryk JS, Ailles LA, Datti A, Barrett JW, Boutros PC, Nichols AC.

Oncotarget · research-article; journal article · DOI 10.18632/oncotarget.25436

Bibliografisk träff 2016-02-01

Sensitivity Profiles of Human Prostate Cancer Cell Lines to an 80 Kinase Inhibitor Panel.

Burke AJ, Ali H, O'Connell E, Sullivan FJ, Glynn SA.

Anticancer Res · research support, non-u.s. gov't; journal article

Bibliografisk träff 2015-09-29

Impact of cyclin-dependent kinase CDK4 inhibition on eryptosis.

Lang E, Zelenak C, Eberhard M, Bissinger R, Rotte A, Ghashghaeinia M, Lupescu A, Lang F, Qadri SM.

Cell Physiol Biochem · research support, non-u.s. gov't; journal article · DOI 10.1159/000430241

Bibliografisk träff 2014-09-03

Small-molecule inhibitors of SETD8 with cellular activity.

Blum G, Ibáñez G, Rao X, Shum D, Radu C, Djaballah H, Rice JC, Luo M.

ACS Chem Biol · brief-report; research support, non-u.s. gov't; journal article; research support, n.i.h., extramural · DOI 10.1021/cb500515r

Bibliografisk träff 2014-06-05

A high through-put screen for small molecules modulating MCM2 phosphorylation identifies Ryuvidine as an inducer of the DNA damage response.

FitzGerald J, Murillo LS, O'Brien G, O'Connell E, O'Connor A, Wu K, Wang GN, Rainey MD, Natoni A, Healy S, O'Dwyer M, Santocanale C.

PLoS One · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pone.0098891

Bibliografisk träff 2000-03-01

5-Arylamino-2-methyl-4,7-dioxobenzothiazoles as inhibitors of cyclin-dependent kinase 4 and cytotoxic agents.

Ryu CK, Kang HY, Lee SK, Nam KA, Hong CY, Ko WG, Lee BH.

Bioorg Med Chem Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/s0960-894x(00)00014-7